TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Scius Pharma Support AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
370
|
542
|
662 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-170
|
-195
|
41 |
| EBITDA |
-172
|
-197
|
41 |
| Total assets |
492
|
701
|
1,060 |
| Current assets |
492
|
701
|
1,060 |
| Current liabilities |
60
|
80
|
61 |
| Equity capital |
431
|
621
|
1,000 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
87.6%
|
88.6%
|
94.3% |
| Turnover per employee |
370
|
542
|
662 |
| Profit as a percentage of turnover |
-45.9%
|
-36.0%
|
6.2% |
| Return on assets (ROA) |
-34.6%
|
-27.8%
|
3.9% |
| Current ratio |
820.0%
|
876.2%
|
1737.7% |
| Return on equity (ROE) |
-39.4%
|
-31.4%
|
4.1% |
| Change turnover |
-155
|
-123
|
-278 |
| Change turnover % |
-29%
|
-18%
|
-30% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.